| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |